-
1
المؤلفون: Amanda L Fish, Michael Beggs, Abigail D. Rostykus, Luis Carbonell, S. Antic, James K. Brown, Tess Rubenstein, Neil N. Trivedi, Pierre P. Massion, Anil Vachani, Mehrdad Arjomandi, H. Yu
المصدر: C110. THE FUTURE OF LUNG CANCER BIOMARKERS: WHERE SHOULD WE LOOK?.
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine, Augment, Former Smoker, Risk assessment, business, Plasma biomarkers, Indeterminate
-
2
المؤلفون: James K. Brown, Alan H.B. Wu, Neil N. Trivedi, Tess Rubenstein, Mehrdad Arjomandi, Heng Yu, Abigail D. Rostykus, Zaid Haddad, Amanda L Fish, Alice Juang, Shan X. Wang, Luis Carbonell, Michael Beggs, Eden Axler, Stephanie Esposito, Sandy Kamer, Bhavin Patel
المصدر: Biomedical research and clinical practice, vol 3, iss 4
Biomedical research and clinical practiceمصطلحات موضوعية: Oncology, medicine.medical_specialty, diagnosis, Article, Clinical Research, Internal medicine, Medicine, pulmonary nodules, Overdiagnosis, Lung cancer, Lung, Cancer, business.industry, Prevention, biomarkers, risk models, General Medicine, medicine.disease, Blood proteins, 4.1 Discovery and preclinical testing of markers and technologies, lung cancer, Biomarker (medicine), business, Indeterminate, Risk assessment, Risk classification, Lung cancer screening, 4.2 Evaluation of markers and technologies
وصف الملف: application/pdf
-
3
المؤلفون: Mehrdad Arjomandi, Doris Vuong, Heng Yu, Alice Juang, Alan Hb Wu, Tess Rubenstein, Amanda L Fish, Michael Beggs, Abigail D. Rostykus, Luis Carbonell, Manpreet Sidhu, Sandy Kamer, Shan X. Wang, Bhavin Patel, James K. Brown, Neil N. Trivedi
المصدر: Biomedical research and reviews, vol 2, iss 3
Biomedical research and reviewsمصطلحات موضوعية: Analyte, diagnosis, Lower risk, Article, Clinical Research, medicine, pulmonary nodules, Lung cancer, Lung, Cancer, Reproducibility, medicine.diagnostic_test, business.industry, Prevention, biomarkers, risk models, Building and Construction, medicine.disease, Blood proteins, Orders of magnitude (mass), lung cancer, Immunoassay, National Lung Screening Trial, Nuclear medicine, business, 4.2 Evaluation of markers and technologies
وصف الملف: application/pdf